News

The company has reported net sales of $5.21 billion in the fourth quarter of 2008 that were essentially flat compared with the fourth quarter of 2007. For the

Dr Berman succeeds Robert Stote, who has been serving as the chief medical officer of Cpex since its spin-off from Bentley Pharmaceuticals in June 2008. Dr Stote, who

The new clinical development offices and expanded workforce will help Covance expedite the execution of clinical studies and build strategic relationships with investigators and sites in countries well

In his role at Quest, Leon held several positions over time, including director of molecular diagnostics, senior director of biotechnology department, and vice president of applied genomics. “We

MDX-1203 is comprised of a potent cytotoxic prodrug chemically linked with a fully human anti-CD70 antibody. CD70 is expressed in renal cell carcinoma (RCC), leukemias, lymphomas and other

Total revenue for the fourth quarter of 2008 increased to $31.2 million, compared with $19.3 million in the fourth quarter of 2007. Product revenue from the Oncotype DX(R)

Fiscal 2009 first quarter highlights Gross profit grew 5% to $15.3 million on increased sales and continued operating leverage. Effective tax rate declined to 33.6% due primarily to

During the first nine months of the fiscal year ending March 31, 2009 (April 1 to December 31, 2008), the Japanese economy experienced a further deceleration in its

The SonoDrugs collaboration aims to develop new materials and drug nanocarrier systems for improved localized drug delivery that can be activated by ultrasound waves. Magnetic resonance imaging (MRI)